The present invention is related to a compound according to formula (I),
wherein R
1
and R
2
are each and independently selected from the group comprising alkyl;
n is any integer between 1 and 4;
R
3
is an acyl selected from the group comprising lysyl, ornithyl, 2,4-diaminobutyryl, histidyl and an acyl moiety according to formula (II),
wherein m is any integer from 1 to 3 and
Y
−
is a pharmaceutically acceptable anion.
本发明涉及一种化合物,其
化学式为(I),其中R1和R2分别独立地选自包括烷基的群体;n是1到4之间的任意整数;R3是从包括赖
氨酰基,鸟
氨酰基,2,4-二
氨基丁酰基,组
氨酰基和
化学式(II)所示的酰基中选择的酰基,其中m是1到3之间的任意整数,Y-是药学上可接受的阴离子。